Drawing for BYONZINE

USPTO serial 90383313

BYONZINE

Reviewed by CopyMark Law Group

Reg. 6586926Status 700Renewal
Filing date
Status date
Registration date
Dec 14, 2021
Examiner
I, DAVID C
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with BYONZINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $325

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

E. Anthony Figg

E. Anthony Figg ROTHWELL FIGG ERNST & MANBECK PC901 New York Avenue, N.W.Suite 900 EastWashington, DC 20001

Goods and services

ClassDescriptionStatusFirst use
042Scientific and technological services, namely, scientific research, analysis, testing, diagnostic testing in the field of medicine, namely, cancers and autoimmune diseases, and the treatment of illnesses; Pharmaceutical research and development; biomedical research; medical research; scientific chemical and biological laboratory services; scientific laboratory services relating to pharmaceuticals; Development of pharmaceutical products and ingredients; laboratory research and analysis, namely, chemical research and analysis, biological research and analysis; research and design services for the pharmaceutical industry; research and development of new products for others; research into new drugs, namely, pharmaceutical drug development services; research and design services for the pharmaceutical industry; research and development of new products for others; research into new drugs, namely, pharmaceutical drug development services; Scientific research in the field of proteins, antibodies, microorganisms and cells; Scientific research and development in antibody technology; design and development of medical technologies; research and development of antibody conjugates combined with a drug or chemical for the treatment of cancerACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 21, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 21, 2022ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Nov 21, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 21, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 14, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 28, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 28, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 8, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 24, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 23, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 23, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 22, 2021ALIEASSIGNED TO LIE—
Jul 8, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 8, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 8, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 8, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 8, 2021DOCKASSIGNED TO EXAMINER—
Feb 23, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 18, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance